Bianca A W Hoeben

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. doi request reprint PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 51:1076-83. 2010
  2. doi request reprint Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 129:870-8. 2011
  3. doi request reprint Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2
    Laura K van Dijk
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands and
    J Nucl Med 54:2118-24. 2013
  4. doi request reprint Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Acta Oncol 52:1257-71. 2013
  5. doi request reprint 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 54:532-40. 2013
  6. ncbi request reprint Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome
    Anne I J Arens
    Department of Nuclear Medicine, Radboud University Medical Center, P O Box 9101, 6500 HB, Nijmegen, The Netherlands
    Eur J Nucl Med Mol Imaging 41:915-24. 2014
  7. pmc Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Medical Center, P, O, Box 9101, Nijmegen 6500 HB, The Netherlands
    BMC Cancer 14:130. 2014

Detail Information

Publications7

  1. doi request reprint PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 51:1076-83. 2010
    ....
  2. doi request reprint Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 129:870-8. 2011
    ..i., respectively). Our study suggests that, at optimal cetuximab imaging dose, (111) In-cetuximab can be used for visualization of EGFR expression in head-and-neck squamous cell carcinoma using SPECT...
  3. doi request reprint Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2
    Laura K van Dijk
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands and
    J Nucl Med 54:2118-24. 2013
    ..The aim of this study was to develop and characterize the (111)In-cetuximab-F(ab')2 tracer to image EGFR targeting in vivo...
  4. doi request reprint Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Acta Oncol 52:1257-71. 2013
    ..In this context, we focus this review on the widely used PET tracer (18)F-FDG and PET tracers depicting hypoxia and proliferation; two well-known radiation resistance mechanisms...
  5. doi request reprint 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    J Nucl Med 54:532-40. 2013
    ....
  6. ncbi request reprint Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome
    Anne I J Arens
    Department of Nuclear Medicine, Radboud University Medical Center, P O Box 9101, 6500 HB, Nijmegen, The Netherlands
    Eur J Nucl Med Mol Imaging 41:915-24. 2014
    ..In this study, three advanced semiautomatic PET segmentation methods for delineation of the proliferative tumour volume (PV) before and during (chemo)radiotherapy were compared and related to clinical outcome...
  7. pmc Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors
    Bianca A W Hoeben
    Department of Radiation Oncology, Radboud University Medical Center, P, O, Box 9101, Nijmegen 6500 HB, The Netherlands
    BMC Cancer 14:130. 2014
    ..The goal of this study was to systematically analyze if immunohistochemical (IHC) assessment of molecular markers, involved in treatment resistance, and 18F-FDG PET parameters could accurately distinguish separate HNC tumors...